Consumers in the U.K. say trust is an important factor when it comes to the companies where they shop. This is why Newsweek ...

DAEJEON, Jan. 17 (Korea Bizwire) — A team of researchers at the Korea Advanced Institute of Science and Technology (KAIST) has developed an innovative camera system that achieves both high-speed ...

It provides range of vision beyond one focal point. Bausch + Lomb launched the enVista Aspire monofocal and toric IOLs in the European Union, according to a press release. Using intermediate ...

Miss Universe CEO Anne Jakrajutatip shocked the pageant community when she praised Miss Universe winner Victoria Kjær Theilvig's blond hair and blue eyes, calling them "the best." "We have blond ...

1 Andy Orth, CEO of City Therapeutics is quoted in the press release 1 on this news, saying, “We are excited to collaborate with Bausch + Lomb’s team of eye health experts, who share our vision to ...

The software on the drones would automatically restrict you from flying over sensitive places including runways, the White House, and power plants. Controversially, as anti-China sentiment has ...

London, UK, 13 January 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing significant unmet needs in cardiometabolic disease, has entered into an exclusive licensing ...

Brent Saunders, Bausch and Lomb CEO, joins 'Money Movers' to discuss how Saunders has changed the portfolio in his time as chief executive, what the growth is like for Bausch and Lomb, and much more.

In the US, enVista Aspire is the first Low-Cyl toric IOL below 1.5D at the IOL plane, enhancing treatment options. Bausch + Lomb announced the commercial launch of its enVista Aspire monofocal and ...

With its new CEO in­stalled this week, City Ther­a­peu­tics is aim­ing to cap­i­tal­ize on the mo­men­tum in sign­ing a new deal.